The global esophagoscopes and gastroscopes market currently stands at US$ 1.2 billion and is predicted to exhibit a CAGR of 5.4%. The market is predicted to rake in revenue worth US$ 2.0 billion by the end of 2033.
Esophagoscope and gastroscope sales currently account for an 8% share of the global endoscopes market. Increasing preference for minimally invasive procedures is expected to drive demand for laparoscopic instruments such as arthroscopes, bronchoscopes, laparoscopes, etc.
Esophagoscopes and Gastroscopes Market Size (2023) | US$ 1.2 Billion |
---|---|
Predicted Market Worth (2033) | US$ 2.0 Billion |
Global Market Growth Rate (2023 to 2033) | 5.4% CAGR |
North America Market Share | 35% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Innovations in the medical sector have led to a rise in the application of mechanical instruments for treating and diagnosing esophageal ailments. Since the geriatric population is growing globally, esophageal cancer cases are rapidly rising.
The utility of esophagoscopes for various diagnostic and surgical processes is aiding the market growth. The recent increase in global inflammatory bowel disease cases has shifted market trends. This has propelled the need for wide application devices for early disease detection. Such factors cohesively foster the fruitful application of advanced esophagoscopes and gastroscopes in the healthcare sector.
Despite the steadily improving market prospects, there are factors such as the risk of infection from contamination, anesthesia-induced allergic reactions, and organ perforation risks. These factors are expected to hinder the market growth during the forecast period. Key players need to focus on developing variants that are more efficient and pose fewer side effects.
Currently, the advanced endoscopes available in the market are expensive. This can be attributed to the use of specialized components in their manufacturing processes. Hence, there is a need to develop a cheaper alternative for the sophisticated components of these advanced models. This would open the market to a larger consumer segment, triggering steady revenue increment.
Particulars | Details |
---|---|
H1, 2022 | 5.35% |
H1, 2023 Projected | 5.55% |
H1, 2023 Outlook | 4.65% |
BPS Change - H1, 2023 (O) - H1, 2023 (P) | (-) 90 ↓ |
BPS Change - H1, 2023 (O) - H1, 2022 | (-) 70 ↓ |
The global esophagoscopes & gastroscopes market is inclined by the rising prevalence of gastrointestinal diseases and growing preference for minimally invasive procedures. Macroeconomic, regulatory, and industrial variables all have an impact on market growth. The launch of innovative products by key manufacturers for better performance is a key market development factor.
The esophagoscopes & gastroscopes market is projected to decrease by 70 Basis Share Points (BPS) in H1-2023 when compared to H1-2022, according to the FMI study. Moreover, analysis of the H1-2023 outlook and H1- 2022 projected period estimated growth rate indicated a falling variation in the BPS value by 90 BPS.
The dip in the BPS value for the esophagoscopes & gastroscopes market is majorly attributed to a decline in the volume of endoscopic procedures during the past few years.
Other market segments, on the other hand, are likely to perform well and accomplish beneficial growth projections in the next few years of the forecast years. This is due to the development of innovative products such as video gastroscopes and dual-channel endoscopes.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The incidence of gastrointestinal diseases has risen substantially over the past few years, and this has majorly influenced the sales of esophagoscopes and gastroscopes. As a result, demand for esophagoscopes and gastroscope equipment rose at 4.9% CAGR from 2017 to 2022, with sales revenue in 2022 reaching US$ 1.1 billion.
The market is expected to register a higher CAGR between 2023 and 2033, owing to key market drivers.
Short Term (2023 to 2026): The sales of bronchoscopes and arthroscopes are anticipated to rise during the initial phase. This can be attributed to the recent rise in the popularity of laparoscopic surgeries and procedures. In addition, the steadily expanding investment into healthcare infrastructure and rising purchase power are also positively impacting market prospects.
Medium Term (2026 to 2029): The heavy investments into the healthcare infrastructure during the initial phases could yield mid-term results. As a result of the expanding healthcare amenities, product adoption could reach new heights during this phase. In addition, long-term government investments into healthcare could hasten product adoption in public healthcare systems.
Owing to an increase in demand for pet care, sales of veterinary gastroscopes are also expected to see a rise in this phase. In addition, the increasing prevalence of obesity, bad lifestyle choices, improper diet, rising preference for minimally invasive procedures, etc., are some additional factors that guide the market potential.
Long Term (2029 to 2033): Towards the end of the forecast period, the esophagoscope and gastroscope manufacturing, assembling, and operating technologies could rapidly transform. The advancement of technology coupled with product innovations could ultimately transform the market outlook. During this phase, the market could attract a wider consumer base. This can be attributed to factors such as efficient and precise early disease detection. Further, harnessing the capabilities of robotics, machine learning, and Artificial Intelligence is anticipated to bolster the market.
During the current forecast period, the market is expected to grow at a CAGR of 5.4%.
Veterinary Gastrocopes and Pediatric Gastroscopes to See Rising Sales in North America
FMI research details the global esophagoscopes and gastroscopes industry landscape in regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
The North American esophagoscopes and gastroscopes market is currently dominating the global landscape while accounting for 33.4% of global esophagoscopes and gastroscope sales. Developed healthcare infrastructure and wide availability of treatment procedures create a lucrative setting for the sales of laparoscopes, arthroscopes, and other laparoscopic instruments in North America.
Sales of esophagoscopes and gastroscopes in Latin America are likely to account for 7.6% of the global revenue in 2023. Demand in this region is majorly driven by developing healthcare systems of emerging economies.
European Market Rises in Prominence Due to Rise in Geriatric Population & Veterinary Diagnoses
Increasing geriatric population and rising prevalence of gastrointestinal diseases in Europe are expected to drive esophagoscope and gastroscope consumption at a good pace over the forecast period. The Europe esophagoscopes and gastroscopes industry currently hold a market share of 27.2% in the global marketplace.
Increasing pet health awareness and veterinary care in Europe is also expected to propel the demand for veterinary gastroscopes over the coming years.
Esophagoscope and gastroscope shipments are expected to see a rise from regions such as East Asia, South Asia, and the Pacific over the forecast period. The increase in demand in these regions can be attributed to developing healthcare infrastructure, increasing healthcare expenditure, rising technological proliferation, etc.
High birth rates in the regions of East Asia, South Asia, and the Pacific are expected to drive demand growth for pediatric gastroscopes over the forecast period.
The lowest market share is held by the MEA esophagoscopes and gastroscopes market due to underdeveloped healthcare systems in this region and less technological proliferation in medical procedures. This is expected to change over the forecast period, and the esophagoscopes and gastroscopes consumption is expected to rise.
Esophagoscopes & Gastrophagoscopes Market:
Attributes | Esophagoscopes & Gastrophagoscopes Market |
---|---|
CAGR (2023 to 2033) | 5.2% |
Market Value (2033) | US$ 2.0 billion |
Growth Factor | Technological innovation in healthcare, rising investment in healthcare infrastructure, increase in global disposable income |
Opportunity | In recent times consumers are starting to develop a penchant for advanced diagnostic devices and procedures. By increasing product efficiency, key players can expand their consumer base |
Key Trends | Key players are launching advanced variants such as video gastroscopes |
Endoscopy Devises Market:
Attributes | Endoscopy devises Market |
---|---|
CAGR (2023 to 2033) | 7.8% |
Market Value (2033) | US$ 105.9 billion |
Growth Factor | The procedure is less invasive, and more affordable, preference for disposable endoscopy devices that reduce any risk of infections. |
Opportunity | Preference of both patients and doctors for less invasive procedures; has carved out a lucrative market for advanced variants with high-definition cameras |
Key Trends | Due to rising instances of cancer, key players are launching new variants with multiple capabilities that aid in cancer diagnoses |
Single-Use Cystoscope Market:
Attributes | Single-Use Cystoscope Market |
---|---|
CAGR (2023 to 2033) | 5.1% |
Market Value (2033) | US$ 165.3 billion |
Growth Factor | Increasing technological advancement, application in diagnosing urinary tract infections, ability to ensure sterility |
Opportunity | Following the latest sustainability practices, key players need to endeavor to create eco-friendly variants to reduce their carbon footprint |
Key Trends | Key players are heavily investing in the research and development of single-use cystoscopes to increase product efficiency |
Region | North America |
---|---|
Country | United States of America |
CAGR | 5.8% |
Market Value (2033) | US$ 648.5 Million |
Region | Europe |
---|---|
Country | United Kingdom |
CAGR | 4.3% |
Market Value (2033) | US$ 85.0 Million |
Region | Asia Pacific |
---|---|
Country | China |
CAGR | 7.3% |
Market Value (2033) | US$ 240.8 Million |
Region | Asia Pacific |
---|---|
Country | India |
CAGR | 6.20% |
Market Value (2033) | US$ 92.2 Million |
Region | Asia Pacific |
---|---|
Country | Japan |
CAGR | 4.50% |
Market Value (2033) | US$ 113.4 Million |
Increasing Obesity to Drive Sales of Laparoscopic Instruments in the USA
The USA has seen a substantial increase in the incidence of gastrointestinal diseases. This is expected to rise further as the prevalence of obesity increases in the USA over the forecast period. The USA has seen an increase in cases of stomach cancer, gastrointestinal bleeding, and functional gastrointestinal diseases. This has subsequently increased the number of endoscopies performed in the nation.
Poor lifestyle choices, bad eating habits, and smoking are some of the major factors driving the esophagoscopes and gastroscopes market in the USA. Instruments like laparoscopes, arthroscopes, bronchoscopes, gastroscopes, etc., are expected to see an increase in sales over the forecast period.
Increasing pet care awareness is also expected to drive sales of veterinary gastroscopes in the USA. During the forecast period, the USA market is expected to register a CAGR of 5.8%. The market is anticipated to record a revenue of US$ 648.5 million by 2033.
Demand for Pediatric Gastroscopes and Veterinary Gastroscopes Soar
Being the second most populated nation in the world makes India an extremely lucrative market for pediatric products and pediatric care. The nation has a high birth rate, and hence the need for pediatric products is also high. The aforementioned factors are anticipated to drive the sales of pediatric gastroscopes in India over the next few years.
India also sees an increase in pet ownership and pet adoption. There is also rising pet care awareness which has created a booming demand for veterinary gastroscopes.
The rapidly developing healthcare infrastructure is majorly expected to guide the demand for esophagoscopes and gastroscope systems in India. During the forecast period, the Indian market is expected to register a CAGR of 6.2%.
Disposable Gastroscopes to See Major Upshift in Demand Due to Ease of Operation
Flexible endoscopes are gaining popularity for their increasing scope of application for multiple diagnostic and treatment procedures. Compared to rigid endoscopes, flexible endoscopes are easier to operate in complex diagnostic and treatment procedures. Single-use gastroscopes and disposable gastroscopes have seen a hike in demand as awareness about hospital-acquired infections increases all over the world.
Increasing focus on medical waste concerns is expected to hamper the adoption of single-use gastroscopes and disposable gastroscopes. However, this is anticipated to be solved by the manufacturers launching sustainable and eco-friendly products.
Hospitals Emerge as the Top End-user Segment, Fueled by Innovations & Investment
Currently, medical device manufacturers are keen on gaining clearance from competent authorities for their gastroscopes and esophagoscopes. With technological innovations, medical device manufacturers can develop advanced variants for the healthcare segment. As a result, hospitals are increasingly adopting advanced esophagoscopes & gastroscopes for diagnosis and treatment. Owing to these factors, this segment has emerged as the top end-user between 2023 and 2033. The hospital end-user segment is expected to register a CAGR of 5.2% during the forecast period.
The esophagoscopes and gastroscopes industry is a highly consolidated marketplace with select players leading and dominating the market. New esophagoscopes and gastroscope vendors will have to come up with innovative products to penetrate the market. Hence, startups might have to embrace untapped technologies to capture consumer interest.
Leading Startups to Lookout For
Start-up Company | EndoChoice |
---|---|
Country | United States |
Description | EndoChoice, an Atlanta-based healthcare startup, is known for its launch of a gastroscope that offers a wider field of view for the physician. |
Start-up Company | Ankon Technologies |
---|---|
Country | China |
Description | Ankon Technologies have come up with a revolutionary, innovative, and gastrointestinal capsule that offers an endoscopic robotic system. It is known as the Ankon NaviCam® gastroscope capsule and has the State Food and Drug Administration's Class III for medical clearance. |
Company | PENTAX Medical |
---|---|
Details | PENTAX Medical primarily manufactured highly advanced, innovative endoscopic products and services for healthcare providers |
Recent Developments | In September 2020, PENTAX Medical, a healthcare leader in therapeutic endoscopy, announced the launch of new video gastroscopes. The new line of J10 Series Ultrasound Video Gastroscopes comes with an ergonomic design and enhanced maneuverability as a EUS (endoscopic ultrasound) solution. The new line also has increased linear scope scan and increased frequency capabilities for better performance. |
Company | FUJIFILM Healthcare Americas Corporation |
---|---|
Details | FUJIFILM Healthcare Americas Corporation is a global pioneer in advanced diagnostic solutions that meet the demand of the evolving healthcare system |
Recent Developments | In October 2021, FUJIFILM Healthcare Americas Corporation, a renowned name in the endoscopic imaging industry, announced the launch of its new endoscope - Fujifilm's EI-740D/S, which is a new dual-channel endoscope that is the first dual-channel endoscope to be approved by the USA FDA for upper as well as lower gastrointestinal diagnostics and treatment. |
Company | Ambu A/S |
---|---|
Details | Ambu or Ambu A/S is a Danish company known for developing single-use diagnostic, life-supporting as well as endoscopy solutions, catering to various end users. |
Recent Developments | In February 2022, Ambu A/S sought clearance for their latest gastroscope variant from FDA. |
The global esophagoscopes and gastroscopes market is slated to progress at a CAGR of 5.4% from 2023 to 2033.
Global sales of esophagoscopes and gastroscopes are estimated to attain a valuation of US$ 2.0 billion by 2033.
In 2023, the global esophagoscopes and gastroscopes market is set to be valued at US$ 1.2 billion.
The North American esophagoscopes and gastroscopes market holds a dominant share of 35% in the global market.
Tier-1 manufacturers of esophagoscopes and gastroscopes are Olympus Corporation and Pentax Medical Company.
By end-user, the hospital segment currently dominated the market. By, product type, the flexible endoscope segment dominates the market at a CAGR of 5.0% predicted between 2023 and 2033.
1. Executive Summary | Esophagoscopes & Gastroscopes Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Rigid Endoscope
5.3.2. Flexible Endoscope
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Hospitals
6.3.2. Ambulatory Surgical Centers
6.3.3. Specialty Clinics
6.3.4. Diagnostic Centers
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Italy
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. Rest of Europe
10.2.2. By Product Type
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. India
11.2.1.3. Australia
11.2.1.4. Japan
11.2.1.5. Rest of Asia Pacific
11.2.2. By Product Type
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End User
11.4. Key Takeaways
12. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Saudi Arabia
12.2.1.2. South Africa
12.2.1.3. Rest of MEA
12.2.2. By Product Type
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Product Type
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Product Type
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Product Type
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Product Type
13.4.2.2. By End User
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Product Type
13.5.2.2. By End User
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Product Type
13.6.2.2. By End User
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Product Type
13.7.2.2. By End User
13.8. Italy
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Product Type
13.8.2.2. By End User
13.9. Spain
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Product Type
13.9.2.2. By End User
13.10. Russia
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Product Type
13.10.2.2. By End User
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Product Type
13.11.2.2. By End User
13.12. India
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Product Type
13.12.2.2. By End User
13.13. Australia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Product Type
13.13.2.2. By End User
13.14. Japan
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Product Type
13.14.2.2. By End User
13.15. Saudi Arabia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Product Type
13.15.2.2. By End User
13.16. South Africa
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Product Type
13.16.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Shanghai AoHua Photoelectricity Endoscope Co. Ltd.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Olympus Corporation
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Pentax Medical Company
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Fujifilm Holdings Corp.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Karl Storz GmbH & Co. KG
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. PerkinElmer Inc
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Richard Wolf GmbH
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Zhejiang Shendasiao Medical Instrument Co., Ltd.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Aohua Endoscopy Co., Ltd.
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Maxer Endoscopy GmbH
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports